Difference between revisions of "Communications Committee"
Jump to navigation
Jump to search
m |
m (→Scope) |
||
| Line 4: | Line 4: | ||
* [https://docs.google.com/spreadsheets/d/1w-kGTqObvK-mVtjja1d-Yxs9fwNZnAZmdwUklB2zvBc/edit#gid=1807281004 Roster] | * [https://docs.google.com/spreadsheets/d/1w-kGTqObvK-mVtjja1d-Yxs9fwNZnAZmdwUklB2zvBc/edit#gid=1807281004 Roster] | ||
| + | |||
| + | ==Communications Committee Mission Statement== | ||
| + | QIBA Communications will educate and publicize the impact of image quantification on therapeutic and drug clinical trials and patient disease staging and follow-up. | ||
| + | Oversee educational component | ||
| + | |||
==Scope== | ==Scope== | ||
| Line 9: | Line 14: | ||
:* tbd | :* tbd | ||
:* tbd | :* tbd | ||
| − | |||
==Meetings/Call Summaries== | ==Meetings/Call Summaries== | ||
Revision as of 02:06, 30 January 2021
- Chairs: Anne M. Smith, PhD; Majid Chalian, MD
- RSNA Staff Support: Julie Lisiecki
Communications Committee Mission Statement
QIBA Communications will educate and publicize the impact of image quantification on therapeutic and drug clinical trials and patient disease staging and follow-up. Oversee educational component
Scope
The Communications Committee supports QIBA Biomarker Committees by providing visibility to QIBA efforts.
- tbd
- tbd
Meetings/Call Summaries
Monthly Tcons (Contact Julie for details)
Approved call summaries: